Oric Pharmaceuticals (ORIC) Amortizatization of Intangibles (2020 - 2026)
Oric Pharmaceuticals (ORIC) posted Amortizatization of Intangibles of -$162000.0 for Q1 2026, down 167.5% on a QoQ basis from $240000.0 in Q4 2025, and down 118.37% year-over-year from $882000.0 in Q1 2025.
Oric Pharmaceuticals (ORIC) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Oric Pharmaceuticals' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at -$162000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 118.37% year-over-year to -$162000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 81.41% YoY) and the FY2025 annual result came in at $2.3 million, down 71.62% from the prior year.
- Amortizatization of Intangibles was -$162000.0 for Q1 2026 at Oric Pharmaceuticals, down from $240000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.3 million in Q2 2024 and bottomed at -$162000.0 in Q1 2026.
- A 5-year average of $1.0 million and a median of $861000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 2150.0% — and 2026, when it slumped 118.37%.
- Oric Pharmaceuticals' Amortizatization of Intangibles stood at $620000.0 in 2022, then jumped by 242.42% to $2.1 million in 2023, then declined by 23.03% to $1.6 million in 2024, then slumped by 85.31% to $240000.0 in 2025, then plunged by 167.5% to -$162000.0 in 2026.
- Business Quant data shows ORIC's Amortizatization of Intangibles at -$162000.0 in Q1 2026, $240000.0 in Q4 2025, and $587000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Oric Pharmaceuticals | 1.30 Bn | 1.30 Bn | - | -162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162,000.00 |
| Mar 31, 2026 | -162,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Mar 31, 2025 | 882,000.00 |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 2.23 Mn |
| Mar 31, 2024 | 2.23 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Dec 31, 2023 | 2.12 Mn |